GSK lung drug succeeds in big UK study, after earlier miss

LONDON, May 24 (Reuters) - GlaxoSmithKline's new

inhaled medicine Breo proved significantly better than standard

care in a large British study that tested it in everyday use,

providing a fillip for the product after the failure of another

big trial in 2015.

Read more